Then, we analyzed how PADI3 expression was upregulated in patients with endometrial cancer, and that high expression of PADI3 was associated with poor prognosis, suggesting that PADI3 may be involved in regulating endometrial cancer progression. The gene discussed is PADI3; the disease is endometrial cancer.